PGHH FY26 PAT up 19% to ₹857 Crore; Recommends ₹60 Final Dividend
Procter & Gamble Hygiene and Health Care Ltd. reported FY26 sales of ₹4290 crore (flat YoY) and PAT of ₹857 crore, up 19%. Q4 FY26 sales were ₹941 crore (-5% YoY) with PAT at ₹153 crore (-2% YoY). The company recommended a final dividend of ₹60 per share, making total dividend ₹255 per share.
The announcement of annual financial results, significant PAT growth, and a substantial dividend recommendation directly impacts investor sentiment and the company's valuation.
The company reported a significant 19% increase in Profit After Tax for the fiscal year, driven by product mix and efficiency improvements, alongside a recommended final dividend. Although Q4 saw a slight dip, the overall annual performance and dividend announcement are positive.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced its audited financial results for the fiscal year ended March 31, 2026. The company reported sales of ₹4290 crore for the fiscal year, which remained flat compared to the previous year. Profit After Tax (PAT) for the fiscal year increased by 19% to ₹857 crore, attributed to improved product mix, productivity, and efficiency.
For the fourth quarter ended March 31, 2026, PGHH recorded sales of ₹941 crore, a decrease of 5% year-on-year. PAT for the quarter was ₹153 crore, down by 2% compared to the same period last year.
It is noted that the company changed its financial year from July 1-June 30 to April 1-March 31. The previous fiscal year covered a 9-month period (July 1, 2024, to March 31, 2025), and performance is indexed against the comparable 12-month period (April 1, 2024, to March 31, 2025).
Managing Director V Kumar highlighted the company's continued focus on consumer-centric innovations and strengthening go-to-market capabilities. Investments were made in amplifying communication for the Whisper Period Panty and upgrading formulations for products like Whisper Choice and Whisper Bindazzz Nights. The Vicks VapoRub formulation was also enhanced for improved efficacy.
PGHH also announced a recommended final dividend of ₹60 per equity share for the fiscal year ended March 31, 2026, subject to shareholder approval at the 62nd Annual General Meeting. Combined with the interim dividend of ₹195 per share, the total dividend payout for the fiscal year amounts to ₹255 per share.
The company reaffirmed its commitment to its CSR program, P&G Shiksha, which supports the education of underprivileged children.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.